The treatment and natural course of peripheral and central vertigo;Periphere und zentrale vestibuläre Schwindelformen: Therapie und Verlauf

Deutsches Arzteblatt International

Volumn 110, Issue 29-30, 2013, Pages 505-515

  Strupp, Michael ^a,b   Dieterich, Marianne ^a   Brandt, Thomas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMINOPYRIDINE; ANTIVERTIGO AGENT; BETAHISTINE; CARBAMAZEPINE; CHLORZOXAZONE; DEXAMETHASONE; GENTAMICIN; METHYLPREDNISOLONE; METOPROLOL SUCCINATE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ANTIBIOTIC THERAPY; AREFLEXIA; ARTICLE; BENIGN PAROXYSMAL POSITIONAL VERTIGO; BILATERAL VESTIBULOPATHY; CEREBELLAR ATAXIA; CEREBELLUM DISEASE; CORTICOSTEROID THERAPY; DISEASE COURSE; DROP ATTACK; HUMAN; MENIERE DISEASE; MIGRAINE; NAUSEA AND VOMITING; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PERILYMPH FISTULA; POSITIONAL VERTIGO; RECURRENCE RISK; VERTIGO; VESTIBULAR DISORDER; VESTIBULAR FUNCTION; VESTIBULAR MIGRAINE; VESTIBULAR NEURONITIS; VESTIBULAR PAROXYSMIA;

BRAIN DISEASES; CAUSALITY; COMORBIDITY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EVIDENCE-BASED MEDICINE; HUMANS; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME; VERTIGO; VESTIBULAR DISEASES;

EID: 84906329090     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2013.0505     Document Type: Article

References (40)

1. Brandt T, Dieterich M, Strupp M: Vertigo-Leitsymptom Schwindel. 2nd ed. Heidelberg: Springer Medizin; 2012
2. Strupp M, Brandt T: Diagnosis and treatment of vertigo and dizziness. Dtsch Arzteblatt Int 2008; 105: 173-80
3. Neuhauser HK: Epidemiology of vertigo. Curr Opin Neurol 2007; 20: 40-6
4. Geser R, Straumann D: Referral and final diagnoses of patients assessed in an academic vertigo center. Front Neurol 2012; 3: 169
5. Brandt T, Zwergal A, Jahn K, Strupp M: Integrated center for research and treatment of vertigo, balance and ocular motor disorders. Nervenarzt 2009; 80: 875-86
6. Diener HC, Weimar C: Leitlinien für Diagnostik und Therapie in der Neurologie. 5th ed. Stuttgart: Thieme; 2012
7. Strupp M, Thurtell MJ, Shaikh AG, Brandt T, Zee DS, Leigh RJ: Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol 2011; 258: 1207-22
8. Strupp M, Schuler O, Krafczyk S, et al.: Treatment of downbeat nystagmus with 3,4-diaminopyridine: A placebo-controlled study. Neurology 2003; 61: 165-70
9. Kremmyda O, Zwergal A, la FC, Brandt T, Jahn K, Strupp M: 4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion. J Neurol 2013; 260: 321-3
10. Strupp M, Kalla R, Claassen J, et al.: A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 2011; 77: 269-75
11. Schniepp R, Wuehr M, Neuhaeusser M, et al.: 4-Aminopyridine and cerebellar gait: A retrospective case series. J Neurol 2012; 259: 2491-3
12. Jeong SH, Kim JS, Shin JW, et al.: Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol 2013; 260: 832-8
13. Gufoni M, Mastrosimone L, Di NF: Repositioning maneuver in benign paroxysmal vertigo of horizontal semicircular canal. Acta Otorhinolaryngol Ital 1998; 18: 363-7
14. Yacovino DA, Hain TC, Gualtieri F: New therapeutic maneuver for anterior canal benign paroxysmal positional vertigo. J Neurol 2009; 256: 1851-5
15. Brandt T, Huppert D, Hecht J, Karch C, Strupp M: Benign paroxysmal positioning vertigo: A long-term follow-up (6-17 years) of 125 patients. Acta Otolaryngol 2006; 126: 160-3
16. Strupp M, Hüfner K, Sandmann R, et al.: Central oculomotor disturbances and nystagmus: A window into the brainstem and cerebellum. Dtsch Arztebl Int 2011; 108: 197-204
17. Strupp M, Zingler VC, Arbusow V, et al.: Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004; 351: 354-61
18. Fishman JM, Burgess C, Waddell A: Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis). Cochrane Database Syst Rev 2011: CD008607
19. Strupp M, Arbusow V, Maag KP, Gall C, Brandt T: Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis. Neurology 1998; 51: 838-44
20. Hillier SL, McDonnell M: Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev 2011; 2: CD005397
21. Brandt T, Huppert T, Hüfner K, Zingler VC, Dieterich M, Strupp M: Longterm course and relapses of vestibular and balance disorders. Restor Neurol Neurosci 2010; 28: 69-82
22. Huppert D, Strupp M, Theil D, Glaser M, Brandt T: Low recurrence rate of vestibular neuritis: A long-term follow-up. Neurology 2006; 67: 1870-1
23. Brandt T, Schautzer F, Hamilton D, et al.: Vestibular loss causes hippocampal atrophy and impaired spatial memory in humans. Brain 2005; 128: 2732-41
24. Zingler VC, Cnyrim C, Jahn K, et al.: Causative factors and epidemiology of bilateral vestibulopathy in 255 patients. Ann Neurol 2007; 61: 524-32
25. Kirchner H, Kremmyda O, Hüfner K, et al.: Clinical, electrophysiological, and MRI findings in patients with cerebellar ataxia and a bilaterally pathological head-impulse test. Ann N Y Acad Sci 2011; 1233: 127-38
26. Szmulewicz DJ, Waterston JA, Halmagyi GM, et al. Sensory neuropathy as part of the cerebellar ataxia neuropathy vestibular areflexia syndrome. Neurology 2011;76: 1903-10
27. Zingler VC, Weintz E, Jahn K, et al.: Follow-up of vestibular function in bilateral vestibulopathy. J Neurol Neurosurg Psychiatry 2007; 79: 284-8
28. Gürkov R, Flatz W, Louza J, Strupp M, Krause E: In vivo visualization of endolymphatic hydrops in patients with Meniere's disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol 2011; 268: 1743-8
29. Strupp M, Barndt T: Peripheral vestibular disorders. Curr Opin Neurol 2013; 26: 81-9
30. Pullens B, van Benthem PP: Intratympanic gentamicin for Meniere's disease or syndrome. Cochrane Database Syst Rev 2011; 3: CD008234
31. Garduno-Anaya MA, Couthino De TH, Hinojosa-Gonzalez R, Pane- Pianese C, Rios-Castaneda LC: Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: A twoyear prospective, placebo-controlled, double-blind, randomized trial. Otolaryngol Head Neck Surg 2005; 133: 285-94
32. Casani AP, Piaggi P, Cerchiai N, Seccia V, Franceschini SS, Dallan I: Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Oto - laryngol Head Neck Surg 2012; 146: 430-7
33. Strupp M, Huppert D, Frenzel C, et al.: Long-term prophylactic treatment of attacks of vertigo in Meniere's disease-comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol 2008; 128: 520-4
34. Lezius F, Adrion C, Mansmann U, Jahn K, Strupp M: High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Meniere's disease: A case series. Eur Arch Oto - rhinolaryngol 2011; 268: 1237-40
35. Ihler F, Bertlich M, Sharaf K, Strieth S, Strupp M, Canis M: Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in Guinea pigs in vivo. PLoS One 2012; 7: e39086
36. Huppert D, Strupp M, Brandt T: Long-term course of Meniere's disease revisited. Acta Otolaryngol 2010; 130: 644-51
37. Brandt T, Dieterich M: Vestibular paroxysmia: vascular compression of the eighth nerve? Lancet 1994; 343: 798-9
38. Strupp M, von Stuckrad-Barre S, Brandt T, Tonn JC: Teaching NeuroImages: Compression of the eighth cranial nerve causes vestibular paroxysmia. Neurology 2013; 80: e77
39. Hüfner K, Barresi D, Glaser M, et al.: Vestibular paroxysmia: diagnostic features and medical treatment. Neurology 2008; 71: 1006-14
40. Lempert T, Olesen J, Furman J, et al.: Vestibular migraine: diagnostic criteria : Consensus document of the Barany Society and the International Headache Society. Nervenarzt 2013; 84: 511-6.